MREO
Mereo BioPharma
MREO
MREO
63 hedge funds and large institutions have $212M invested in Mereo BioPharma in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 19 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
25% less capital invested
Capital invested by funds: $283M → $212M (-$71M)
40% less call options, than puts
Call options by funds: $237K | Put options by funds: $392K
47% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 17
Holders
63
Holding in Top 10
1
Calls
$237K
Puts
$392K
Top Buyers
| 1 | +$41.8M | |
| 2 | +$13.6M | |
| 3 | +$6.5M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$2.71M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.42M |
Top Sellers
| 1 | -$19.7M | |
| 2 | -$5.38M | |
| 3 | -$5.24M | |
| 4 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$5.13M |
| 5 |
TLP
Tri Locum Partners
New York
|
-$3.97M |